Functional outcomes of multi-condition collaborative care and successful ageing: Results of randomised trial

BMJ (Online)

Volumn 343, Issue 7833, 2011, Pages 1083-

  Von Korff, Michael ^a   Katon, Wayne J ^b   Lin, Elizabeth H B ^a   Ciechanowski, Paul ^b   Peterson, Do ^a   Ludman, Evette J ^a   Young, Bessie ^b   Rutter, Carolyn M ^a,c  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES CONTROL; DIABETES MELLITUS; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF CARE; SHEEHAN DISABILITY SCALE; SOCIAL DISABILITY; UNITED STATES; WORLD HEALTH ORGANIZATION DISABILITY ASSESSMENT SCHEDULE SCALE;

ACTIVITIES OF DAILY LIVING; AGED; CORONARY DISEASE; DELIVERY OF HEALTH CARE, INTEGRATED; DEPRESSION; DIABETES MELLITUS; DISABILITY EVALUATION; FEMALE; HEMOGLOBINS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTORS; SELF CARE; TREATMENT OUTCOME; WASHINGTON;

EID: 82255183572     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d6612     Document Type: Article

References (41)

1. Gureje O. The pattern and nature of mental-physical comorbidity: specific or general. In: Von Korff M, Scott KM, Gureje O, eds. Global perspectives on mental-physical comorbidity in the WHO world mental health surveys. Cambridge University Press, 2009:51-83.
2. Scott KM, Von Korff M, Alonso J, Angermeyer MC, Bromet E, Fayyad J, et al. Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med 2008;26:1-11.
3. Von Korff M, Ormel J, Katon W, Lin EHB. Disability and depression in medical patients: a longitudinal analysis. Ach Gen Psychiatry 1992;49:91-100.
4. Ormel J, Von Korff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on psychological problems in general health care. JAMA 1994;272:1741-8. (Pubitemid 24372001)
5. Von Korff M, Scott KM, Gureje O, eds. Global perspectives on mental-physical comorbidity in the WHO world mental health surveys. Cambridge University Press, 2009.
6. McMichael AJ, McKee M, Shkolnikov V, Valkonen T. Mortality trends and setbacks: global convergence or divergence. Lancet 2004;363:1155-9. (Pubitemid 38452791)
7. Christensen KM, Doblhammer G, Rau R, Vaupel JW. Aging populations: the challenges ahead. Lancet 2009;374:1196-208.
8. Jozan P. The epidemiological future. Health Policy 1991;19:19-32.
9. Von Korff M. Global perspectives on mental-physical comorbidity. In: Von Korff M, Scott KM, Gureje O, eds. Global perspectives on mental-physical comorbidity in the WHO world mental health surveys. Cambridge University Press, 2009:1-11.
10. Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987;237:143-9. (Pubitemid 17095916)
11. Rowe JW, Kahn RL. Successful aging. Gerontologist 1997;37:433-40. (Pubitemid 27353643)
12. Guralnik JM, Kaplan GA. Predictors of healthy aging: prospective evidence from the Alameda County Study. Am J Public Health 1989;79:703-8. (Pubitemid 19142907)
13. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980;303:130-5. (Pubitemid 10076605)
14. Larson EB. Prospects for delaying the rising tide of worldwide, late-life dementias. Int Psychogeriatr 2010;22:1196-202.
15. Mor V. The compression of morbidity hypothesis: a review of research and prospects for the future. J Am Geriatr Soc 2005;53(9 suppl):S308-9. (Pubitemid 41783142)
16. Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 2006;14:6-20. (Pubitemid 43122169)
17. Lin EHB, Katon W, Von Korff M, Tang L, Williams JW, Kroenke K, et al. for the IMPACT investigators. Effect of improving depression care on pain and function among older adults with arthritis: a randomized controlled trial. JAMA 2003;290:2428-34. (Pubitemid 37430542)
18. Williams JW Jr, Katon W, Lin EH, Nöel PH, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015-24.
19. Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman J, et al. Collaborative care management of major depression among low-income, predominately Hispanic subjects with diabetes. Diabetes Care 2010;33:706-13.
20. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79. (Pubitemid 46155798)
21. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA 2009;302:2095-103.
22. Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301:2099-110.
23. Simon GE. Clinical implications. In: Von Korff M, Scott KM, Gureje O, eds. Global perspectives on mental-physical comorbidity in the WHO world mental health surveys. Cambridge University Press, 2009:297-301.
24. Lewis SJ. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy. J Fam Practice 2009;58:S32-40.
25. Cote I, Gregoire JP, Moisan J. Health-related quality-of-life measurement in hypertension: a review of randomized controlled drug trials. Pharmacoeconomics 2000;18:435-50.
26. Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging 2004;21:377-93. (Pubitemid 38608506)
27. Anderson RT, Venkat Narayan KM, Feeney P, Goff D, Ali MK, Simmons DL, et al. for the ACCORD Investigators. Effect of intensive glycemic lowering of health-related quality of life in type 2 diabetes. Diabetes Care 2011;34:807-12.
28. Katon W, Lin EH, Von Korff M, Ciechanowski P, Ludman E, Young B, et al. Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study. Contemp Clin Trials 2010;31:312-22.
29. Lin EHB, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, Rutter C, et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease and depression: a randomized controlled trial. Ann Fam Med 2011 (in press).
30. Katon WJ, Lin EHB, Von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Multi-condition collaborative care for chronic illness and depression. N Engl J Med 2010;363:2611-20.
31. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010;8:348-53.
32. Riddle MC, Rosenstock J, Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-6. (Pubitemid 37339502)
33. Rollnick S, Miller W. What is motivational interviewing? Behav Cogn Psychother 1995;23:325-34. (Pubitemid 26132330)
34. Katon W, Ludman E, Simon G. The depression helpbook. Bull Publishing Company, 2003.
35. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan disability scale. Int J Psychiatry Med 1997;27:93-105. (Pubitemid 27407503)
36. Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization disability assessment schedule 2.0. Bull World Health Organ 2010;88:815-23.
37. Scholes D, La Croiz AZ, Wagner EH, Grothaus L, Hecht JA. Tracking progress toward national health objective in the elderly: what do restricted activity days signify? Am J Public Health 1991;81:485-8.
38. Lindholt JS, Ventegodt S, Henneberg EW. Development and validation of QoL5 for clinical databases. A short, global and generic questionnaire based on an integrated theory of the quality of life. Eur J Surgery 168:107-13.
39. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins symptom checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 1974;7:79-110.
40. Sturm R, Unutzer J, Katon W. Effectiveness research and implications for study design: sample size and statistical power. Gen Hosp Psychiatry 1999;21:274-83. (Pubitemid 29455043)
41. Katon W, Russo J, Lin E, Schmittdiel J, Ciechanowski P, Ludman E, et al. Cost-effectiveness of a multicondition collaborative care intervention. Arch Gen Psychiatry 2011 (in press).